SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioLase Technology, Inc. (BLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jack Siegel who wrote (492)1/26/1999 10:58:00 PM
From: Karl Drobnic  Read Replies (1) of 706
 
I'd rather have Schein out there doing the selling than BLTI trying to build a sales organization from the ground up. Just the investment in going to exhibitions is substantial. If BLTI can position itself as a manufacturer, and Schein can make the sales, then BLTI doesn't have the overhead problems of a sales division. Manufacturing, when you have a niche product with patent protection, can be very profitable. Also, if Schein works out, it might give BLTI more time and money to devote to getting some of their other products to market, like DermaLase and Laser Skin Toner. I think an established distributor makes a lot of sense for BLTI. Their worries end at the loading dock if Schein is the right fit for BLTI.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News